---

Pascal Soriot

Executive Director and Chief Executive Officer, AstraZeneca

Revenue: $26.1 billion (2014)
Employees: circa 50,000

Judge’s comment: “Pascal Soriot is an archetype of the transformative chief executive. Few such inarguable examples exist of a leader who moves into a struggling, large global firm and, in less than two years, produces such dramatic and positive change. Before Soriot’s tenure, financial analysts considered AstraZeneca as one of the ‘dogs’ of the global pharmaceutical industry. Today, AstraZeneca’s pipeline is rated as one of the top three in the industry and stock is up 65 percent. Soriot led the company in a successful defense against acquisition by Pfizer - no easy feat, and an unthinkable outcome before this transformation.”

www.astrazeneca.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015